Health Care

Commentary

Make Telehealth Coverage a Permanent Medicare Feature

When the Trump administration loosened telemedicine restrictions for Medicare patients in March 2020, the move was seen as temporary. The COVID-19 pandemic was in its early days. Read the op-ed here:
Biosimilars

Fixing The Regulatory Flaws Biosimilars Face Will Help Patients

About a month ago, the Centers for Medicare & Medicaid Services announced the next 15 drugs that will be subject to the maximum fair price (MFP) negotiation process. These negotiations are essentially a means to impose price controls on selected medicines. If the Trump Administration truly wants to help patients, ...
Commentary

We Can’t Afford Timidity in Revamping Medicaid

Last week, the House of Representatives passed a budget resolution by the narrowest of margins. The most controversial component of the bill concerns Medicaid. Democrats have castigated the resolution on the grounds that it would make steep cuts to the joint federal-state public healthcare entitlement. Even some Republicans have expressed ...
Commentary

President and Congress Should Eliminate Wasteful Healthcare Subsidies

Big insurers are beginning to panic. At the end of this year, the generous COVID-era taxpayer subsidies they’ve enjoyed on coverage sold through Obamacare’s exchanges will expire. Good. The subsidies represent billions of dollars in corporate welfare for insurance companies — and obscure how premiums have surged under Obamacare. Read ...
Drug Importation

Sally Pipes – The World’s Medicine Chest

This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
Commentary

End Federal Welfare For Universities, Insurers

When it comes to government spending, President Trump may just be the DOGE who caught the car. Thanks in large part to Elon Musk’s Department of Government Efficiency, Americans are learning about all sorts of waste that only the most ardent readers of government reports and websites knew of. Read ...
Blog

Waiting for Care: The Sick Reality of Single-Payer Health Systems

A Vancouver hospital with staff shortages cancelled more than 100 heart surgeries in the first six months of last year, according to a new report. Patients queued up — again — to wait for care. Such stories abound in Canada and the United Kingdom, where the government operates and pays ...
Commentary

Why House Republican Budget Cuts Should Start With Health Insurance Subsidies

Last night, House Republicans passed a critical budget proposal for the upcoming fiscal year that calls for $2 trillion in spending cuts over 10 years to get America’s fiscal house in order and address our $35 trillion national debt. Congress should start by addressing one of the economy’s biggest pain ...
Commentary

RFK Jr. Can Breathe New Life Into HHS

Speaking to agency staffers last week, newly installed Secretary of Health and Human Services Robert F. Kennedy, Jr., insisted that “nothing is off limits” in his fight against chronic disease. It’s an encouraging message. HHS is in desperate need of modernization. Read the entire op-ed in Newsmax.
Drug Prices

New Brief: ‘Maximum Fair Price’ Policy Would Bring New Costs to Nevada Taxpayers, Put Patient Access to Health Care at Risk

SACRAMENTO – Nevada taxpayers could face millions in new bureaucratic costs and patients will likely see less access to life-saving drugs if state government mandates so-called “Maximum Fair Price” price controls on prescription drugs, finds a new brief released today by the Center for Medical Economics and Innovation at the ...
Commentary

Make Telehealth Coverage a Permanent Medicare Feature

When the Trump administration loosened telemedicine restrictions for Medicare patients in March 2020, the move was seen as temporary. The COVID-19 pandemic was in its early days. Read the op-ed here:
Biosimilars

Fixing The Regulatory Flaws Biosimilars Face Will Help Patients

About a month ago, the Centers for Medicare & Medicaid Services announced the next 15 drugs that will be subject to the maximum fair price (MFP) negotiation process. These negotiations are essentially a means to impose price controls on selected medicines. If the Trump Administration truly wants to help patients, ...
Commentary

We Can’t Afford Timidity in Revamping Medicaid

Last week, the House of Representatives passed a budget resolution by the narrowest of margins. The most controversial component of the bill concerns Medicaid. Democrats have castigated the resolution on the grounds that it would make steep cuts to the joint federal-state public healthcare entitlement. Even some Republicans have expressed ...
Commentary

President and Congress Should Eliminate Wasteful Healthcare Subsidies

Big insurers are beginning to panic. At the end of this year, the generous COVID-era taxpayer subsidies they’ve enjoyed on coverage sold through Obamacare’s exchanges will expire. Good. The subsidies represent billions of dollars in corporate welfare for insurance companies — and obscure how premiums have surged under Obamacare. Read ...
Drug Importation

Sally Pipes – The World’s Medicine Chest

This week, we present a special presentation of our recent webinar with Sally Pipes, PRI President, CEO, and Thomas W. Smith Fellow in Health Care Policy, discussing her new book, The World’s Medicine Chest: How America Achieved Pharmaceutical Supremacy – and How to Keep It (Encounter Books). The book explores ...
Commentary

End Federal Welfare For Universities, Insurers

When it comes to government spending, President Trump may just be the DOGE who caught the car. Thanks in large part to Elon Musk’s Department of Government Efficiency, Americans are learning about all sorts of waste that only the most ardent readers of government reports and websites knew of. Read ...
Blog

Waiting for Care: The Sick Reality of Single-Payer Health Systems

A Vancouver hospital with staff shortages cancelled more than 100 heart surgeries in the first six months of last year, according to a new report. Patients queued up — again — to wait for care. Such stories abound in Canada and the United Kingdom, where the government operates and pays ...
Commentary

Why House Republican Budget Cuts Should Start With Health Insurance Subsidies

Last night, House Republicans passed a critical budget proposal for the upcoming fiscal year that calls for $2 trillion in spending cuts over 10 years to get America’s fiscal house in order and address our $35 trillion national debt. Congress should start by addressing one of the economy’s biggest pain ...
Commentary

RFK Jr. Can Breathe New Life Into HHS

Speaking to agency staffers last week, newly installed Secretary of Health and Human Services Robert F. Kennedy, Jr., insisted that “nothing is off limits” in his fight against chronic disease. It’s an encouraging message. HHS is in desperate need of modernization. Read the entire op-ed in Newsmax.
Drug Prices

New Brief: ‘Maximum Fair Price’ Policy Would Bring New Costs to Nevada Taxpayers, Put Patient Access to Health Care at Risk

SACRAMENTO – Nevada taxpayers could face millions in new bureaucratic costs and patients will likely see less access to life-saving drugs if state government mandates so-called “Maximum Fair Price” price controls on prescription drugs, finds a new brief released today by the Center for Medical Economics and Innovation at the ...
Scroll to Top